Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Assessing the impact of disease prevalence on access and pricing of rare disease drugs in England

Comparison of orphan drug assessments from NICE versus the NHS

- PMLiVE

Taking steps to sustainability: Porterhouse celebrates achieving ISO 14001 certification

Porterhouse Medical Group is proud to announce that we have passed the ISO (International Organization for Standardization) 14001 certification in environmental management.As part of our mission to improve lives, we...

Porterhouse Medical Group

- PMLiVE

Brain tumour awareness month: giving research a more humane face

Did you know that March is Brain Tumour Awareness Month? With brain tumour cases rising, funds are urgently needed to help find a cure for this swift, relentless killer.

11 London

- PMLiVE

New date announced for Communiqué Awards 2021!

The awards will now take place on 1 September 2021 at what is hoped will be a live event

- PMLiVE

GCI Health’s UK team announces three senior promotions

Kim Walker, Hannah Morris and Clare Yianni take on new leadership roles

- PMLiVE

Efficacy data from US trial for AZ/Oxford vaccine raises concerns over possible ‘incomplete view’

AZ will engage ‘immediately’ with DSMB to share primary analysis with up-to-date efficacy data

- PMLiVE

CureVac expands COVID-19 vaccine trial protocol to include variant specification

Company is aiming to ensure its vaccine efficacy data is 'meaningful' against new virus variants

- PMLiVE

Roche, Regeneron’s COVID-19 antibody cocktail cuts hospitalisation or death by 70%

Phase 3 trial is evaluating the therapy in high-risk non-hospitalised patients with COVID-19

- PMLiVE

Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer

Therapy hit both primary endpoints of overall survival and radiographic progression-free survival

- PMLiVE

A lonely planet

The impact of social isolation and loneliness due to COVID-19 has not yet fully revealed itself

- PMLiVE

EU-UK COVID-19 vaccine row continues as export ban discussion looms

EU officials are set to discuss imposing a vaccine export ban this week

Roche Basel Switzerland

Roche’s Tecentriq yields positive data in early stage NSCLC

PD-L1 inhibitor improved disease-free survival in phase 3 IMpower010 study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links